5-Amino-1MQ Dosing: 50-150mg/Day Oral Protocol

5-Amino-1MQ is a small molecule NNMT inhibitor used for fat loss — taken orally in capsule form, not by injection. It is not a peptide in the traditional sense but is commonly grouped with research peptides in the metabolic optimization space.

No human clinical trials exist. All protocols are based on preclinical animal data and community experience. This is not medical advice.

Quick Reference: Community Protocol

Start at 50 mg daily for 1-2 weeks to assess tolerance, then increase to 100-150 mg daily. Most community protocols settle at 100 mg as the standard maintenance dose. No reconstitution needed — oral capsule.

Cycling Details

The 8-12 week on / 4-8 week off cycle accounts for the absence of long-term human safety data. Gradual dose escalation is recommended rather than a traditional loading phase.

Week 1-2: 50 mg daily to assess GI tolerance, energy changes, and side effects. Week 3-12: Increase to 100-150 mg daily if well-tolerated. The off period allows assessment of sustained metabolic benefits after discontinuation.

Morning dosing is preferred to align with peak metabolic activity. Take at the same time daily for consistent NNMT inhibition.

Routes of Administration

Oral (only route): Capsule form, typically available in 50 mg capsules. High oral bioavailability — Caco-2 cell assays showed excellent passive and active membrane transport with no detectable efflux (Neelakantan et al., 2018). Stable at room temperature. No reconstitution, syringes, or refrigeration needed.

Not an injectable. Unlike most compounds on this site, 5-Amino-1MQ is a small molecule designed for oral delivery.

Where These Numbers Come From

5-Amino-1MQ dosing is entirely community-derived, extrapolated from preclinical animal research. No human clinical trials have been conducted.

Key Preclinical Study (Neelakantan et al., 2018): Treatment in diet-induced obese mice produced progressive body weight loss, reduced white adipose tissue mass and adipocyte size, decreased total cholesterol, and no changes in food intake — effects were metabolic, not appetite-driven. The study used 20 mg/kg SC three times daily in mice.

NNMT as Target (Kraus et al., 2014): NNMT knockdown in white adipose tissue and liver protected against diet-induced obesity by increasing cellular energy expenditure. This established the mechanistic rationale for NNMT inhibition.

Combined Approaches (Neelakantan et al., 2022): NNMT inhibition with reduced-calorie diet produced dramatic adiposity reduction in DIO mice, normalizing metabolic parameters and establishing a distinct gut microbiome.

Community oral doses (50-150 mg daily) are based on allometric scaling from mouse studies, oral bioavailability data, and several years of community trial and error.

Stacking Protocols

5-Amino-1MQ + MOTS-c (Metabolic Stack)

5-Amino-1MQ + Tesofensine

Complementary mechanisms — metabolic enhancement plus appetite suppression. Monitor energy levels; multiple metabolic compounds can compound stimulant-like effects.

Side Effects & Safety

• Mild GI discomfort — most common, usually transient in the first week
• Slight stimulant effect — increased energy/alertness, especially early on
• Headaches — occasional, typically mild and dose-related
• Mild insomnia — if taken too late in the day
• No human clinical safety data — all safety information from preclinical studies and community reports
• No liver toxicity observed in animal studies at therapeutic doses
• Unknown drug interactions — theoretically could interact with NAD+-dependent pathways

Frequently Asked Questions

What is the standard 5-Amino-1MQ dose?

50-150 mg orally once daily. Start at 50 mg, increase to 100 mg after 1-2 weeks based on tolerance. Cycle 8-12 weeks on, 4-8 weeks off.

Is 5-Amino-1MQ taken orally or by injection?

Orally in capsule form. It has high membrane permeability, making it one of the few compounds in this space that doesn't require injection.

Does 5-Amino-1MQ suppress appetite?

No — it works through metabolic pathways (NNMT inhibition, NAD+ restoration) to increase cellular energy expenditure in fat tissue. Animal studies showed no changes in food intake despite significant weight loss.

How long should a 5-Amino-1MQ cycle last?

8-12 weeks on, 4-8 weeks off. No long-term human data exists to guide continuous use.

Can 5-Amino-1MQ be stacked?

Yes — popular stacks include MOTS-c for mitochondrial support and tesofensine for complementary appetite suppression. Assess individual response before combining.

Related Guides

• Tesofensine Dosing Guide — Complementary weight management compound
• MOTS-c Dosing Guide — Mitochondrial peptide for metabolic stacking
• SS-31 Dosing Guide — Mitochondrial support peptide
• Semaglutide Dosing Guide — GLP-1 agonist comparison
• Peptide Stacking Guide — Principles for combining compounds
• Calculate Your 5-Amino-1MQ Cycle Cost — Estimate cost for your protocol

References

For educational and research purposes only. This is not medical advice. 5-Amino-1MQ has no human clinical trials; all dosing is community-derived.